IL122247A0 - Use of sulfamic acid derivatives acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels - Google Patents

Use of sulfamic acid derivatives acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels

Info

Publication number
IL122247A0
IL122247A0 IL12224796A IL12224796A IL122247A0 IL 122247 A0 IL122247 A0 IL 122247A0 IL 12224796 A IL12224796 A IL 12224796A IL 12224796 A IL12224796 A IL 12224796A IL 122247 A0 IL122247 A0 IL 122247A0
Authority
IL
Israel
Prior art keywords
pct
medicament
manufacture
acid derivatives
sulfamic acid
Prior art date
Application number
IL12224796A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL122247A0 publication Critical patent/IL122247A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL12224796A 1995-08-04 1996-07-08 Use of sulfamic acid derivatives acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels IL122247A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US303195P 1995-08-04 1995-08-04
PCT/US1996/011366 WO1997005868A1 (en) 1995-08-04 1996-07-08 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels

Publications (1)

Publication Number Publication Date
IL122247A0 true IL122247A0 (en) 1998-04-05

Family

ID=21703764

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12224796A IL122247A0 (en) 1995-08-04 1996-07-08 Use of sulfamic acid derivatives acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels

Country Status (27)

Country Link
US (1) US6117909A (xx)
EP (1) EP0841913B1 (xx)
JP (1) JPH11510184A (xx)
KR (1) KR19990036127A (xx)
CN (1) CN1192140A (xx)
AT (1) ATE232097T1 (xx)
AU (1) AU716255B2 (xx)
BG (1) BG63863B1 (xx)
CA (1) CA2221729A1 (xx)
CZ (1) CZ26198A3 (xx)
DE (1) DE69626118T2 (xx)
DK (1) DK0841913T3 (xx)
EA (1) EA002435B1 (xx)
EE (1) EE9800037A (xx)
ES (1) ES2191762T3 (xx)
GE (1) GEP20012511B (xx)
HR (1) HRP960341A2 (xx)
HU (1) HUP9900668A3 (xx)
IL (1) IL122247A0 (xx)
NO (1) NO980466D0 (xx)
NZ (1) NZ312571A (xx)
PL (1) PL185943B1 (xx)
PT (1) PT841913E (xx)
SK (1) SK12598A3 (xx)
UA (1) UA46030C2 (xx)
WO (1) WO1997005868A1 (xx)
ZA (1) ZA966617B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1584333A3 (en) * 1998-01-28 2009-04-29 Warner-Lambert Company LLC Use of acetylcoenzime A inhibitors for treating Alzheimer's disease
HUP0102880A3 (en) * 1998-07-21 2002-11-28 Warner Lambert Co Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
IL149145A0 (en) * 1999-11-05 2002-11-10 Warner Lambert Co Prevention of plaque rupture by acat inhibitors
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) * 2002-03-12 2005-09-06 Igt Gaming device having varying risk player selections
EP3709986B1 (en) 2017-11-14 2023-11-01 Merck Sharp & Dohme LLC Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
CN111344287B (zh) 2017-11-14 2023-12-19 默沙东有限责任公司 作为吲哚胺2，3-双加氧酶(ido)抑制剂的新型取代的联芳基化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
EP0555351B1 (en) * 1990-10-30 1994-12-28 Warner-Lambert Company Oxysulfonyl carbamates
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

Also Published As

Publication number Publication date
ZA966617B (en) 1997-02-18
KR19990036127A (ko) 1999-05-25
CZ26198A3 (cs) 1998-07-15
JPH11510184A (ja) 1999-09-07
ES2191762T3 (es) 2003-09-16
AU6454196A (en) 1997-03-05
DE69626118D1 (de) 2003-03-13
PT841913E (pt) 2003-06-30
GEP20012511B (en) 2001-08-27
UA46030C2 (uk) 2002-05-15
HRP960341A2 (en) 1998-02-28
EP0841913A1 (en) 1998-05-20
ATE232097T1 (de) 2003-02-15
BG63863B1 (bg) 2003-04-30
CN1192140A (zh) 1998-09-02
NO980466L (no) 1998-02-03
SK12598A3 (en) 1999-02-11
NO980466D0 (no) 1998-02-03
EA002435B1 (ru) 2002-04-25
CA2221729A1 (en) 1997-02-20
PL185943B1 (pl) 2003-09-30
EP0841913B1 (en) 2003-02-05
DE69626118T2 (de) 2003-11-27
DK0841913T3 (da) 2003-05-05
AU716255B2 (en) 2000-02-24
HUP9900668A2 (hu) 1999-06-28
EE9800037A (et) 1998-08-17
HUP9900668A3 (en) 2000-08-28
US6117909A (en) 2000-09-12
WO1997005868A1 (en) 1997-02-20
BG102222A (en) 1998-09-30
EA199800176A1 (ru) 1998-10-29
PL324908A1 (en) 1998-06-22
NZ312571A (en) 2000-07-28

Similar Documents

Publication Publication Date Title
GR3030356T3 (en) N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
ATE247654T1 (de) Neue heterozyklische verbindungen
DK0759919T3 (da) Azolidindioner som antihyperglykæmiske midler
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
ATE169295T1 (de) 2-phenylbenzo(b>furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische präparate
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
PT98499A (pt) Processo para a preparacao de novas sulfonamidas substituidas e de composicoes farmaceuticas que as contem
DK0874812T3 (da) Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf
ATE268752T1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
IL122247A0 (en) Use of sulfamic acid derivatives acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels
IS1446B6 (is) Ný díhýdróbenzófúran- og króman-karboxamíð efni, aðferð við framleiðslu þeirra og notkun þeirra semlyf
DE69501359T2 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69512208T2 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
MX9709275A (es) Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.
ATE196080T1 (de) Verwendung von diphenylethanderivaten zur herstellung eines arzneimittels zur behandlung von glaukom
DE69616357T2 (de) Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
BR9809313A (pt) Compostos, promedicamento, medicamento, processo para a sua preparação e utilização dos mesmos
SE9401965D0 (sv) New compounds
MX9606133A (es) Nuevos derivados de 1,1-bis(heteroazolil)alcano y su uso como agentes neuroprotectores.